Company
Viking Therapeutics
Viking Therapeutics has 6 drugs tracked on RxWires: 1 in Phase 3, 2 in Phase 2, 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| VK2735 | Phase 3 | Weight Loss |
| VK2809 | Phase 2 | Hyperlipidemia |
| VK5211 | Phase 2 | Hip Fractures |
| VK0214 | Phase 1 | Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) |
| VK2735 Drug | Phase 1 | Obese Adults |
| SC VK3019 | Phase 1 | Obese Adults |
Latest
No recent events.
Follow Viking Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.